Reza Afkhami
Corporate Officer/Principal bei 23ANDME HOLDING CO.
Profil
Reza Afkhami is currently the Chief Corporate Development Officer at 23andMe, Inc. and 23andMe Holding Co. He previously worked as the Senior VP-Corporate Development & Strategy at Global Blood Therapeutics, Inc. and as the Vice President-Corporate Development & Strategy at Surrozen, Inc. Afkhami holds an MBA from the University of California, Berkeley and an undergraduate degree from Georgetown University.
Aktive Positionen von Reza Afkhami
| Unternehmen | Position | Beginn |
|---|---|---|
| 23ANDME HOLDING CO. | Corporate Officer/Principal | 08.05.2023 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01.05.2023 |
Ehemalige bekannte Positionen von Reza Afkhami
| Unternehmen | Position | Ende |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01.03.2023 |
| SURROZEN, INC. | Corporate Officer/Principal | 01.01.2022 |
Ausbildung von Reza Afkhami
| Georgetown University | Undergraduate Degree |
| University of California, Berkeley | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| 23ANDME HOLDING CO. | Health Technology |
| SURROZEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
